Addressing Clinical Management Challenges in the Treatment of Rare, Non-Malignant Hematologic Disorders through Educational Interventions

被引：0
|
作者：
Ackbarali, Sumera [1 ]
Ackbarali, Tariqa [1 ]
Kowalski, Katie [2 ]
Lee, Hans C. [3 ]
Sanchorawala, Vaishali [4 ]
D'Sa, Shirley [5 ]
Chonat, Satheesh [6 ]
de Castro, Carlos M. [7 ]
机构：
[1] PlatformQ Hlth, Lake Worth, FL USA
[2] Natl Org Rare Disorders, Danbury, CT USA
[3] MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX USA
[4] Boston Med Ctr Corp, Amyloidosis Ctr, Boston, MA USA
[5] Univ Coll London Hosp NHS Fdn Trust, Dept Haematol, London, England
[6] Cincinnati Childrens Hosp, Aflac Canc & Blood Disorders Ctr Childrens Health, Atlanta, GA USA
[7] Duke Univ, Duke Canc Inst, Sch Med, Durham, NC USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-157219
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：13057 / 13058
页数：2
相关论文
共 45 条
  • [1] Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders
    Pathak, Swati
    Roth, Michael
    Verma, Amit
    Steidl, Ulrich
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2013, 9 (12) : 1667 - 1675
  • [2] The role of proteasome inhibition in the treatment of malignant and non-malignant hematologic disorders
    Citrin, Rebecca
    Foster, Jessica B.
    Teachey, David T.
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (09) : 873 - 889
  • [3] Comparative Assessment of Significant Psychological Distress In Patients with Malignant and Non-Malignant Hematologic Disorders
    Cole, Craig E.
    McHugh, Vicki L.
    Mathiason, Michelle A.
    Schroeder, Jonean E.
    Bottner, Wayne A.
    Farnen, John P.
    Ettinger, Robert
    Peters, Antoinette
    Dawson, Janette
    Johnston, Kaye L.
    BLOOD, 2010, 116 (21) : 654 - 655
  • [4] Choosing Non-Malignant Hematologic Care Wisely: An Educational Pilot Study for Internal Medicine Residents
    May, Jori E.
    Paschal, Rita D.
    Morris, Jason L.
    Willett, Lisa L.
    BLOOD, 2021, 138
  • [5] Non-myeloablative stem-cell transplantation in the treatment of malignant and non-malignant disorders
    Shimoni, A
    Nagler, A
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2002, 4 (04): : 272 - 279
  • [6] Preventing infectious complications when treating non-malignant immune-mediated hematologic disorders
    Malpica, Luis
    van Duin, David
    Moll, Stephan
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (12) : 1396 - 1412
  • [7] Surgical treatment of non-malignant parotid tumours - Clinical analysis
    Krzymanski, G.
    Domanski, W.
    Przybysz, J.
    Pietka, T.
    Brozyna, B.
    Biernacka, B.
    Chloupek, A.
    PROCEEDINGS OF THE XVIII CONGRESS OF THE EUROPEAN ASSOCIATION FOR CRANIO-MAXILLO FACIAL SURGERY, 2006, : 369 - +
  • [8] Clinical Utility of FDG–PET and PET/CT in Non-malignant Thoracic Disorders
    Sandip Basu
    Babak Saboury
    Tom Werner
    Abass Alavi
    Molecular Imaging and Biology, 2011, 13 : 1051 - 1060
  • [9] Treatment of non-malignant chronic pain: paradigm shift and multidisciplinary management
    Varela, Nicolas
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2022, 45 (02)
  • [10] The future role anaesthesiologist in pain management: treatment of non-malignant pain
    Hamunen, K.
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2009, 53 : 8 - 9
12345